Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study

Официальное название

Community-Based Engagement to Improve Lung Cancer Screening and Outcomes

Обзор

The main goal of this pilot study is to understand the impact of a mobile lung cancer screening clinics in individuals from neighborhoods and communities with less access to resources in Boston, Massachusetts who are at high risk for lung cancer. A secondary goal of this pilot study is to understand how social determinants of health impact these neighborhoods and communities. Another secondary goal of this pilot study is to see if video recording of participants speaking to their future selves and sending the videos back to participants to encourage them to get lung cancer screening after one year can be administered in a mobile lung cancer screening setting. The questions this study aims to answer are: * Is mobile lung cancer screening is feasible and acceptable? * Is collecting social needs data during the mobile lung cancer screening clinics feasible? * Is creating video recordings of patients encouraging their future selves to get lung cancer screening after one year feasible? Participants will: * Complete an intake survey, providing information about their demographic, medical, and social needs information. * Undergo a shared decision-making conversation to determine whether lung cancer screening should be done. * Undergo lung cancer screening. * Undergo a debriefing conversation and fill out an acceptability survey. * Record a video speaking to their future selves about the importance of annual lung cancer screening, with the video to be sent back to them after roughly one year. * Undergo a semi-structured phone interview between four and eight weeks after lung cancer screening date.

Вмешательства

• Лучевая терапия Low-Dose Computed Tomography Scan
  Imaging of chest to screen for lung cancer.

Первичные конечные точки

• Feasibility of mobile lung cancer screening in target communities in Boston, Massachusetts. [Срок оценки: During the intervention.]
• Acceptability of mobile lung cancer screening in target communities in Boston, Massachusetts. [Срок оценки: Between four and eight weeks after the intervention]

Вторичные конечные точки (2)

• Feasibility of collecting social determinants of health data during mobile lung cancer screening clinics in underserved communities in Boston, Massachusetts. [Срок оценки: Pre-intervention]
• Feasibility of administering a video-based intervention to encourage annual lung cancer screening [Срок оценки: From enrollment until the end of the study.]

Критерии участия

Критерии включения

• Ability to understand and the willingness to sign a written informed consent document prior to any study-related procedures.
• Willing to undergo treatment.
• Adults between the ages of 50 and 80 years.
• No recent CT imaging within the last year.
• Currently smokes tobacco or has quit smoking tobacco within the past 15 years.
• Has a tobacco smoking history of at least 20 pack years (i.e. one pack per day for the last 20 years or equivalent).
• Has never been diagnosed with lung cancer.

Критерии исключения

• Adults/children less than 50 years, or greater than 80 years of age.
• Has never smoked tobacco.
• Has smoked tobacco but quit more than 15 years ago.
• Has a tobacco smoking history of less than 20 pack years.
• Presence of major comorbidity(ies) that could prevent treatment.
• Previous diagnosis of lung cancer.
• In the opinion of the investigator, the subject is not an appropriate candidate for the study.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение

Не применимо

Модель

Одна группа

Маскирование

Открытое

Основная цель

Скрининг

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT06909981 · 24-715

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗